tradingkey.logo
tradingkey.logo
Buscar

Ekso Bionics Holdings Inc

EKSO
Añadir a la lista de seguimiento
11.800USD
0.0000.00%
Horarios del mercado ETCotizaciones retrasadas 15 min
3.20BCap. mercado
PérdidaP/E TTM

Más Datos de Ekso Bionics Holdings Inc Compañía

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Información de Ekso Bionics Holdings Inc

Símbolo de cotizaciónEKSO
Nombre de la empresaEkso Bionics Holdings Inc
Fecha de salida a bolsaApr 10, 2013
Director ejecutivoDavis (Scott G)
Número de empleados61
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 10
Dirección101 Glacier Point
CiudadSAN RAFAEL
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94901
Teléfono15109841761
Sitio Webhttps://eksobionics.com/
Símbolo de cotizaciónEKSO
Fecha de salida a bolsaApr 10, 2013
Director ejecutivoDavis (Scott G)

Ejecutivos de Ekso Bionics Holdings Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
67.10K
+59.61%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
30.45K
+17.12%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
25.27K
+26.45%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
5.21K
-201.96%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
67.10K
+59.61%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
30.45K
+17.12%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
25.27K
+26.45%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
5.21K
-201.96%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Ekso Bionics Holdings Inc?

Los cinco principales accionistas de Ekso Bionics Holdings Inc son: Mr. Jerome Wong

¿Cuántas instituciones poseen acciones de Ekso Bionics Holdings Inc (EKSO)?

A fecha de 2026Q1, 66 instituciones poseen acciones de Ekso Bionics Holdings Inc, con un valor de mercado combinado de aproximadamente 972.39K, lo que representa el 3.28% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 491581.00.